Identifying Predictors of Prolonged Levothyroxine Dose Adjustment After Thyroidectomy.

Abstract

BACKGROUND:

Levothyroxine (LT4) is one of the most prescribed drugs in the United States; however, many patients started on LT4 after thyroidectomy suffer from symptoms of hyper- or hypo-thyroidism before achieving euthyroidism. This study aims to describe the time required for dose adjustment before achieving euthyroidism and identify predictors of prolonged dose adjustment (PDA+) after thyroidectomy.

METHODS:

This is a single institution retrospective cohort study of patients who achieved euthyroidism with LT4 therapy between 2008 and 2017 after total or completion thyroidectomy for benign disease. Patients who needed at least three dose adjustments (top quartile) were considered PDA+. Binomial logistic regression was used to identify predictors of PDA+.

RESULTS:

The 605 patients in this study achieved euthyroidism in a median of 116 d (standard deviation 124.9) and one dose adjustment (standard deviation 1.3). The 508 PDA- patients achieved euthyroidism in a median of 101 d and one dose adjustment. The 97 PDA+ patients achieved euthyroidism in a median of 271 d and three dose adjustments. Iron supplementation (odds ratio = 4.4, 95% confidence interval = 1.4-13.5, P = 0.010) and multivitamin with mineral supplementation (odds ratio = 2.4, 95% confidence interval = 1.3-4.3, P = 0.004) were independently associated with PDA+. Age, gender, preoperative thyroid disease, and comorbidities did not independently predict PDA+.

CONCLUSIONS:

After thyroidectomy, achieving euthyroidism can take nearly 4 mo. Iron and mineral supplementation are associated with PDA+. This information can inform the preoperative counseling of patients and suggests that this may expedite achieving euthyroidism.

• Authors: Tenzin S Atruktsang, Nick A Zaborek, Joseph R Imbus, Kristin Long, Susan C Pitt, Rebecca S Sippel, David F Schneider
• Journal: The Journal of surgical research (J Surg Res) Vol. 242 Pg. 166-171 (10 2019) ISSN: 1095-8673 [Electronic] United States
• PMID: 31078901 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: Copyright © 2019 Elsevier Inc. All rights reserved.

Chemical References

• Thyroxine

Topics

• Adult
• Aged
• Dietary Supplements (adverse effects)
• Dose-Response Relationship, Drug
• Female
• Hormone Replacement Therapy (adverse effects, methods, statistics & numerical data)
• Humans
• Hyperthyroidism (blood, chemically induced)
• Hypothyroidism (blood, drug therapy, etiology)
• Male
• Middle Aged
• Prospective Studies
• Retrospective Studies
• Thyroidectomy (adverse effects)
• Thyroxine (administration & dosage, adverse effects, blood)
• Time Factors